Transcranial direct current stimulation (tDCS) has been emerging as a promising intervention to address post‐stroke upper extremity motor impairment. However, trial results have been inconsistent.

The U.S. Food and Drug Administration (FDA) granted a full approval for Symvess on December 19, 2024 for use in adults as a vascular conduit for extremity arterial injury when urgent revascularization ...

Ultrasound is not necessary when computed ... or D-dimer measurement plus bilateral lower extremity venous compression US (if D-dimer level is >500 ng/mL), followed by chest CT if US results ...